Phase I study of the combination of topotecan and irinotecan in children with refractory solid tumors.

Cancer chemotherapy and pharmacology

Volumn 57, Issue 1, 2006, Pages 15-24

  Rodriguez Galindo, Carlos ^a   Crews, Kristine R ^a   Stewart, Clinton F ^a   Furman, Wayne ^a   Panetta, J Carl ^a   Daw, Najat C ^a   Cain, Alvida ^a   Tan, Ming ^a   Houghton, Peter H ^a   Santana, Victor M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE; IRINOTECAN; TOPOTECAN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; DRUG ADMINISTRATION; HUMAN; METABOLISM; NEOPLASM; PHASE 1 CLINICAL TRIAL; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; HUMANS; NEOPLASMS; TOPOTECAN; TREATMENT OUTCOME;

EID: 33644696212     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-005-0030-7     Document Type: Article

References (0)